Details of the Drug

General Information of Drug (ID: DM6DL5K)

Drug Name
Leridistim
Synonyms MPO, Searle; MPO-1; SC-70935; Myelopoietin (1), Searle
Indication
Disease Entry ICD 11 Status REF
Immune System disease 4A01-4B41 Phase 2 [1]
Cross-matching ID
UNII
WYY7RA43DK
DrugBank ID
DB15095
TTD ID
D00GFV

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin 3 receptor (CSF2RB) TTPYS82 IL3RB_HUMAN Agonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00004215) Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia. U.S. National Institutes of Health.
2 Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration. Stem Cells. 2001;19(6):522-33.